Cargando…

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome

Detalles Bibliográficos
Autor principal:	Cantin, André M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884041/ https://www.ncbi.nlm.nih.gov/pubmed/31487198 http://dx.doi.org/10.1164/rccm.201908-1558ED

Ejemplares similares

The NLRP3-Inflammasome in Health and Disease
por: Perri, Anna
Publicado: (2022)

The P2X7 Receptor in Cystic Fibrosis Monocytes: Linking CFTR Deficiency to Inflammation
por: Cantin, André M.
Publicado: (2022)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Gain-of-Function Polymorphisms in Human Inflammasomes: Implications for Cystic Fibrosis
por: Jeansonne, Duane, et al.
Publicado: (2021)

Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)

The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
por: Fan, Jiwen, et al.
Publicado: (2022)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
por: Artlett, Carol M.
Publicado: (2022)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis
por: Tao, Ye, et al.
Publicado: (2020)

Targeting the NLRP3 Inflammasome in Glaucoma
por: Coyle, Sophie, et al.
Publicado: (2021)

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
por: Joshi, Hemant, et al.
Publicado: (2022)

Saturated fatty acid-crystals activate NLRP3 inflammasome
por: Karasawa, Tadayoshi, et al.
Publicado: (2019)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer
por: Overley-Adamson, Beth, et al.
Publicado: (2014)

Editorial: Inflammasome, purinergic signaling, and immunometabolism in oral health and disease
por: Morandini, Ana Carolina, et al.
Publicado: (2023)

Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
por: Zhang, Hong, et al.
Publicado: (2020)

New Therapies to Correct the Cystic Fibrosis Basic Defect
por: Bergeron, Christelle, et al.
Publicado: (2021)

Immunometabolism as predictor of frailty
por: Gostner, Johanna M., et al.
Publicado: (2021)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies
por: Rosa Neto, José Cesar, et al.
Publicado: (2014)

Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases
por: Chen, Yonghu, et al.
Publicado: (2023)

NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection
por: Sergi, Consolato M.
Publicado: (2022)

Targeting the NLRP3 Inflammasome via BTK
por: Weber, Alexander N. R.
Publicado: (2021)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2018
por: Rosa, José C., et al.
Publicado: (2019)

Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016
por: Rosa Neto, Jose C., et al.
Publicado: (2017)

NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
por: Moltrasio, Chiara, et al.
Publicado: (2022)

CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease
por: Myerburg, Mike, et al.
Publicado: (2021)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
por: Akther, Mahbuba, et al.
Publicado: (2021)

Targeting NLRP3 Inflammasome Activation in Severe Asthma
por: Theofani, Efthymia, et al.
Publicado: (2019)

Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020)

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
por: Ozaki, Ema, et al.
Publicado: (2015)

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
por: Huang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8afukeokt6k33m609bmm7qqojj